盈富基金(2800.HK)跌超2% 更改章程禁止美國人購買
格隆匯7月30日丨盈富基金(2800.HK)一度跌2.53%報26.16港元。盈富基金昨晚發公告修改銷售文件,列明“美國人士”不得申請或購買任何基金單位,不論是否依賴於相關美國證券法或其他法律的任何豁免。“美國人士”包括任何美國公民、合法永久居民、根據美國或美國境內任何司法管轄區法律組建的實體,提醒身爲美國人士的單位持有人注意,盈富基金對美國人士而言並非合適的投資工具,如果美國人士於明年6月3日之後繼續持有任何單位,美國法律可能會阻止他們出售或以其他方式買賣其單位。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.